InsidersTradesSigma
Track the 杏林製薬株式会社 stock price and the full directors' dealings record of the company, a publicly traded company based in Japan. Shares are listed on the JP market, under the authority of EDINET (Japan FSA). Operating in the Health Care sector, 杏林製薬株式会社 has recorded 11 public disclosures. Market capitalisation: €63.7bn. The latest transaction was reported on 5 August 2026 (Holding update). Among the most active insiders: Kopernik Global Investers, LLC. The full history is free.
Analysts rate 杏林製薬株式会社 Underperform (bearish), based on 1 analysts. Average price target: JP¥1,100.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
11 of 11 declarations
杏林製薬株式会社 是一家日本公司，专注于健康和制药领域。该公司在 XTKS 市场上市。